Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

doi: 10.1016/S0140-6736(19)32216-0 26. Vandewalker M. Dose-ranging effects of extrafine beclomethasone dipropionate (BDP) delivered via a pressurized metered-dose inhaler (PMDI) in patients with ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

and in different inhaler devices such as dry powder inhalers and propellant-containing metered dose inhalers. Given interclass differences in pharmacological and physiochemical properties of LABAs, ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

HFA-based metered-dose inhalers (MDIs) contain a propellant to deliver ... This system doesn’t apply to albuterol (rescue) inhalers, since most people don’t use this medication on any regular basis.

While your pulmonologist will make recommendations based on best practices, your input can help determine which delivery system (metered dose, dry powder, or soft mist inhaler) is the best suited for ...

Cumulative propellant loss as a function of study duration for Proventil HFA and Ventolin HFA metered-dose inhalers. Albuterol dose per actuation as a function of temperature for Proventil HFA ...

Each patent was directed to a “metered dose inhaler,” “an inhaler ... patents cover aspects of Teva’s ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amneal filed an ANDA application ...

Hannah Garden-Monheit, the director of the FTC's Office of Policy Planning, said in a statement that the decision was "important not only for lowering asthma inhaler costs, it also sets the stage ...